Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : OSI Pharmaceuticals (OSIP) - formerly Oncogene -- Ignore unavailable to you. Want to Upgrade?

To: Micawber who wrote (130)	11/13/2000 9:14:33 AM
From: scaram(o)uche	Read Replies (1) \| Respond to of 447

>> Any opinions? << Yeah. But you already pointed at them. They've designed a trial which will keep the compound going, given some response and a lack of market tox. This is typical Crooke stuff, to end up comparing to historical controls (chemo) and then enter a large "crunch time" trial. He's always been a master of "just in case, we'll have a bait and switch ready" science. Of course everyone is yawning. They've seen this act, as you point to.